TGFB1 and neoplasm: However, during tumor progression, these liver-resident cells can also contribute to immune tolerance by secreting the anti-inflammatory cytokines such as IL-10 and transforming growth factor-beta (TGF-β), and expressing PD-L1, which hinders T-cell activation [20].